in London, who was not involved in the study, told Healthline that the study clearly shows an overall health benefit of starting medication for ADHD. Thomas MacLaren, a member of the Royal College of Psychiatrists in England and a consultant psychiatrist at Re:Cognition Health Ltd. And those diagnosed with ADHD have a “2-fold increased risk of premature death” compared with those who are not, the authors state.ĭr. prevalence is estimated as 9.8% for children and adolescents and 4.4% in adults. Prevalence of the diagnosis worldwide, the study authors note, is 5.9% in youths and 2.5% in adults the U.S. between the ages of 3 and 17 who ever received a diagnosis of ADHD is 10.2%. Centers for Disease Control and Prevention (CDC) as of 2022, the percentage of children in the U.S. The researchers also noted that this is the first study to “rigorously” examine the association of mortality with adults that have ADHD, and given the higher rate of comorbidities in adults with ADHD compared with children and teenagers, it does provide a larger window for examination.Īccording to the U.S. However, the authors point out there has not been much research on this subject previously and that there have only been three studies to examine this link. The study authors note that these findings show correlation, not causation meaning these findings are not proof of a direct link between these medications and mortality rates. How is ADHD associated with higher mortality risk? The results were even more pronounced among unnatural causes of mortality (eg, unintentional injuries, suicide, and accidental poisonings). The crude 2-year mortality rate was nearly twice as low for people who took medication - 17.3 per 10,000 people - than those who did not - 31.8 per 10,000 people. More than half of the people examined in the study - 84,204 - initiated medication treatment within three months of their diagnosis of ADHD 64,296 did not take medication within that period. The medications involved in the study were the six that were licensed in Sweden for the treatment of ADHD from 2007 to 2020: methylphenidate, amphetamine, dexamphetamine, lisdexamfetamine, atomoxetine, and guanfacine. 31, 2018, who had not taken any medication for ADHD for at least 18 months before their diagnosis. The median age for diagnosis of ADHD was 17.4 years, but the study examined people between the ages of 6 and 64 from Jan. The study was published March 12 in JAMA. The study, which incorporated data from national registries in Sweden, utilized a target trial emulation approach to determine whether starting medication for ADHD was associated with mortality in nearly 150,00 people. Study followed people with ADHD for 11 years
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |